Dallah Healthcare Company (TADAWUL:4004)
72.15
-1.45 (-1.97%)
Oct 15, 2026, 3:19 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Buy" and an average price target of SAR 103.97. The average 1-year stock price forecast is 44.10% higher than the current stock price, while the lowest is SAR 85.00 (+17.81%) and the highest is SAR 133.33 (+84.80%).
Price Target: SAR 103.97 (+44.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 3 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 3 | 6 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 10 | 10 |
Financial Forecast
Revenue This Year
4.48B
from 4.07B
Increased by 10.23%
Revenue Next Year
4.98B
from 4.48B
Increased by 11.17%
EPS This Year
5.02
from 4.43
Increased by 13.32%
EPS Next Year
4.75
from 5.02
Decreased by -5.53%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.